Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study

The Lancet Oncology

Volumn 12, Issue 8, 2011, Pages 763-772

  Treasure, Tom ^a   Lang Lazdunski, Loic ^b   Waller, David ^c   Bliss, Judith M ^d   Tan, Carol ^e   Entwisle, James ^f   Snee, Michael ^g   O'Brien, Mary ^h   Thomas, Gill ⁱ   Senan, Suresh ^j   O'Byrne, Ken ^k   Kilburn, Lucy S ^d   Spicer, James ^b   Landau, David ^b   Edwards, John ^l   Coombes, Gill ^d   Darlison, Liz ^c   Peto, Julian ^m  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

^d INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^e ST GEORGE S HOSPITAL   (United Kingdom)

^f WELLINGTON HOSPITAL   (New Zealand)

^g ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ LEICESTER ROYAL INFIRMARY   (United Kingdom)

^j VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^k ST JAMES S HOSPITAL   (Ireland)

^l NORTHERN GENERAL HOSPITAL   (United Kingdom)

^m LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE; MITOMYCIN; PEMETREXED; VINBLASTINE;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; EXTRAPLEURAL PNEUMONECTOMY; FEMALE; HUMAN; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

ADULT; AGED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; PLEURAL NEOPLASMS; PNEUMONECTOMY; TREATMENT OUTCOME;

EID: 79960891922     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70149-8     Document Type: Article

References (25)

1. Peto J, Hodgson JT, Matthews FE, Jones JR Continuing increase in mesothelioma mortality in Britain. Lancet 1995, 345:535-539.
2. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005, 92:587-593.
3. Peto J, Decarli A, La Vecchia C, Levi F, Negri E The European mesothelioma epidemic. Br J Cancer 1999, 79:666-672.
4. Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999, 117:54-63.
5. Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001, 22:788-795.
6. Aziz T, Jilaihawi A, Prakash D The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 2002, 22:298-305.
7. Stewart DJ, Martin-Ucar A, Pilling JE, Edwards JG, O'Byrne KJ, Waller DA The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma. Ann Thorac Surg 2004, 78:245-252.
8. Treasure T, Sedrakyan A Pleural mesothelioma: little evidence, still time to do trials. Lancet 2004, 364:1183-1185.
9. Treasure T, Waller D, Swift S, Peto J Radical surgery for mesothelioma. BMJ 2004, 328:237-238.
10. Tan C, Swift S, Gilham C, et al. Survival in surgically diagnosed patients with malignant mesothelioma in current practice. Thorax 2002, 57(iii):36.
11. Treasure T, Waller D, Tan C, et al. The Mesothelioma and Radical Surgery randomized controlled trial: the MARS feasibility study. J Thorac Oncol 2009, 4:1254-1258.
12. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001, 56:89-108. British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working PartySociety of Cardiothoracic Surgeons of Great Britain and Ireland Working Party.
13. Rusch VW A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 1995, 108:1122-1128.
14. Cao CQ, Yan TD, Bannon PG, McCaughan BC A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma. J Thorac Oncol 2010, 5:1692-1703.
15. Weder W, Stahel RA, Bernhard J, et al. Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 2007, 18:1196-1202.
16. Rea F, Marulli G, Bortolotti L, et al. Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 2007, 57:89-95.
17. Krug LM, Pass HI, Rusch VW, et al. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:3007-3013.
18. De Perrot M, Feld R, Cho BC, et al. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 2009, 27:1413-1418.
19. Van Schil PE, Baas P, Gaafar R, et al. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 2010, 36:1362-1369.
20. Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg 2004, 128:138-146.
21. Opitz I, Kestenholz P, Lardinois D, et al. Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2006, 29:579-584.
22. Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008, 135:620-626.
23. Rice DC, Stevens CW, Correa AM, et al. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 2007, 84:1685-1692.
24. Tilleman TR, Richards WG, Zellos L, et al. Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 2009, 138:405-411.
25. Flores RM, Zakowski M, Venkatraman E, et al. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center. J Thorac Oncol 2007, 2:957-965.